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Abstract
Fibrotic cardiac muscle exhibits high stiffness and low com-
pliance which are major risk factors of heart failure. Although
heat shock transcription factor 1 (HSF1) was identified as an
intrinsic cardioprotective factor, the role that HSF1 plays in
cardiac fibrosis remains unclear. Our study aims to investigate
the role of HSF1 in pressure overload-induced cardiac fibrosis
and the underlying mechanism. HSF1 phosphorylation was
significantly downregulated in transverse aortic constriction
(TAC)-treated mouse hearts and mechanically stretched
cardiac fibroblasts (cFBs). HSF1 transgenic (TG) mice,
HSF1 deficient heterozygote (KO) mice, and their wild-
type littermates were subjected to sham or TAC surgery
for 4 weeks. HSF1 overexpression significantly attenuated
pressure overload-induced cardiac fibrosis and dysfunction.
Conversely, HSF1 KO mice showed deteriorated fibrotic re-
sponse and cardiac dysfunction upon TAC. Moreover, we
uncovered that overexpression of HSF1 protected against fibrotic
response of cFBs to pressure overload. Mechanistically, we ob-
served that the phosphorylation and the nuclear distribution of
the Smad family member 3 (Smad3) were significantly de-
creased in HSF1-overexpressing mouse hearts, while being
greatly increased in HSF1 KO mouse hearts upon TAC, com-
pared to the control hearts, respectively. Similar alteration of
Smad3 phosphorylation and nuclear distribution were found in
isolated mouse cardiac fibroblasts and mechanically stretched
cFBs. Constitutively active Smad3 blocked the anti-fibrotic effect
of HSF1 in cFBs. Furthermore, we found a direct binding of
phosphorylated HSF1 and Smad3, which can be suppressed by
mechanical stress. In conclusion, the present study demonstrated
for the first time that HSF1 acts as a novel negative regulator of
cardiac fibrosis by blocking Smad3 activation.
Key messages
& HSF1 activity is decreased in fibrotic hearts.
& HSF1 overexpression attenuates pressure overload-
induced cardiac fibrosis and dysfunction.
& Deficiency of HSF1 deteriorates fibrotic response and car-
diac dysfunction upon TAC.
& HSF1 inhibits phosphorylation and nuclear distribution of
Smad3 via direct binding to Smad3.
& Active Smad3 blocks the anti-fibrotic effect of HSF1.
Keywords Pressure overload . Cardiac fibrosis . Heat shock
transcription factor 1 . Smad3 . Cardiac dysfunction .
Fibroblasts
Introduction
Cardiac dysfunction is the most common outcome of
longstanding biophysical and biochemical stimuli. Despite
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recent inspiring advances, it remains a leading cause of death
worldwide among elder adults [1]. Pressure overload is a det-
rimental biomechanical stress in primary hypertension and
some valvular heart diseases, and provokes a broad array of
molecular signaling cascades, leading to cardiac damages in-
cluding myocardial hypertrophy, cardiomyocyte death, inter-
stitial fibrosis, ventricular chamber enlargement, and eventu-
ally, heart failure [2, 3]. Accumulating data indicate that car-
diac fibrosis is largely to be blamed for the pathophysiological
changes of heart failure [4, 5]. As an important character of
cardiac dysfunction, cardiac fibrosis aggravates cardiac stiff-
ness and impairs cardiac compliance, eventually resulting in
electromechanical coupling disorders and heart failure [4].
Smad family member 3 (Smad3) is considered as a
central mediator of the myofibroblast transdifferentiation
and extracellular matrix (ECM) synthesis in pressure
overload-induced cardiac fibrosis [6]. In angiotensin II
(AngII) and pressure overload-induced hypertensive mice,
Smad3 deficiency significantly abrogated collagen depo-
sition and inflammation [7, 8]. Multiple cytokines secret-
ed by cardiomyocytes are involved in cardiac fibrosis and
heart failure through modulating the phosphorylation of
Smad3 [9]. Thus, Smad3 has been recently considered
as a promising therapeutic target of cardiac fibrosis and
consequent cardiac stiffness and dysfunction.
Heat shock transcription factor 1 (HSF1) is a transcription
factor of the heat shock genes activated after temperature
stress. HSF1 exists in cytoplasm as an inactive monomer in
a complex with HSP40/HSP70 and HSP90. Phosphorylation
of HSF1 on Ser230 by heat has been shown to contribute to
the transcriptional activity of HSF1. Upon stress, HSF1
trimerizes after dissociating from the chaperone complex
[10]. Activated HSF1 translocates into the nucleus and binds
to the DNA containing heat shock elements (NGAAN) to
activate its target genes [11]. It was demonstrated as a key
factor involved in the adaptive mechanism of transition from
adaptive cardiac hypertrophy to maladaptive heart failure
[12], as well as an essential intrinsic factor protecting the
cardiomyocytes against ischemic injury via interaction with
signal transducer and activator of transcription 3 (STAT3)
[10, 13]. HSF1 was found to be activated in the early phase
of pressure overload and deactivated in the chronic phase (the
maladaptive phase) [12]. We also showed that overexpression
of HSF1 promotes cardiac angiogenesis and blunts cardiac
dysfunction during chronic pressure overload [14].
Considering the general and complicated interactive network
of HSF1 with other signaling molecules in pathological con-
ditions [9, 15], it would be expected that there may exist an
unrevealed association between HSF1 and Smad3 pathway.
In the present study, we used HSF1-overexpressing and
HSF1-deficient mice in vivo, and isolated mouse cardiac fi-
broblasts (cFBs) with gain and loss of HSF1 function in vitro
to investigate the role of HSF1 in cardiac fibrosis induced by
pressure overload, and its underlying mechanisms. We
showed for the first time that HSF1 acts as novel negative
regulator of cardiac fibrosis by blocking Smad3 activation.
Materials and methods
Animal models
The generation of HSF1 - transgenic (TG) and HSF1-deficient
heterozygote (KO) mice have been described previously [11,
16]. HSF1 TG and HSF1 KO mice and their respective wild-
type littermates (WT) (aged from 8 to 10 weeks) were used in
this study. For chronic pressure overload model, mice were
subjected to TAC or sham operation as previously described
[2, 15]. Briefly, mice were injected intraperitoneally with ke-
tamine (25 mg/kg) and were administered 1.5% isoflurane
intranasally for the maintenance of anesthesia during surgery.
Mouse horizontal skin incision was made at the level of 2–3
intercostal space. The descending aorta was isolated, and a 6–
0 silk suture was snared and pulled back around the aorta. A
bent 27-gauge needle was then placed next to the aorta, and
the suture was tied snugly around the needle and the aorta.
After ligation, the needle was quickly removed, the chest and
skin were closed, and the mice were allowed to recover.
Sham-operated mice underwent the same procedure without
constriction. Mouse hearts were excised at 4 weeks after TAC.
All animal experimental protocols were approved by the
Animal Care and Use Committee of Fudan University and
in compliance with BGuide for the Care and Use of
Laboratory Animals (the Guide, NRC 2011).^
Culture and treatments of adult mouse cardiac fibroblasts
Mice were euthanatized by inhalation of 100%CO2 for 5 min.
The mouse hearts were washed by ice-cold PBS to remove the
blood. The mixture of heart fractions and digestion buffer
were left for 1 min undisturbed. The first supernatant that
contained debris and blood cells were discarded. The remain-
ing deposits were digested with 25-ml digestion buffer under
constant stirring at 37 °C for 10 min. Supernatant was collect-
ed into an icy tube containing fibroblast medium (10% FBS,
100 U/ml PenStrep, 1× L-glutamine, 100-μM ascorbic acid in
DMEM/F12). Digestion was repeated until all the tissue has
dissolved. The digested tissue mixtures were spun and re-
suspended in fibroblast medium. The cell suspensions were
pre-plated and cultivated for 2–3 days. The third or fourth
passage of the fibroblasts was used in the present study.
Mouse cFBs were cultured in silicon-based plates for 24 h
and then mechanically stretched to 120% followed by treat-
ment with adenovirus as described previously [15]. To over-
express Smad3, we used replication-defective adenoviral vec-
tors encompassing the entire coding region of Smad3 gene
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under the control of the cytomegalovirus promoter. A similar
adenoviral vector encoding the green fluorescent protein
(GFP) gene was used as a control. We infected the cells with
AdGFP or AdSmad3 at a multiplicity of infection (MOI) of
100, which resulted in transgene expression without toxicity
in 95–100% of the cells. Mouse cFBs were mechanically
stretched for 24 h after the adenovirus infection.
Echocardiographic and hemodynamic measurements
Echocardiography and invasive hemodynamic measure-
ment were performed at 2 or 4 weeks after sham or
TAC surgery. Mice were anesthetized by inhalation of
2% isoflurane. Transthoracic echocardiographic analysis
was performed by using an animal-specific instrument
(VisualSonics Vevo770, VisualSonics Inc., Canada) as
previously described [15]. Mice were anesthetized and
M-mode images of the left ventricle (LV) were recorded.
Cardiac structural and functional parameters included left
ventricular internal end-diastolic dimensions (LVIDd), left
ventricular anterior wall end-diastolic thickness (LVAWd),
and left ventricular ejection fraction (LVEF). All measure-
ments were averaged for five consecutive cardiac cycles
and were carried out by three experienced technicians
who were unaware of the identities of the respective ex-
perimental groups. Hemodynamic assessment was per-
formed by a 1.4-F pressure catheter (SPR 671, Millar
Instruments) inserted into the aorta and LV through the
right common carotid artery after mice were anesthetized
by inhalation of 2% isoflurane. The transducer was con-
nected to Powerlab system (AD Instruments, Castle Hill,
Australia) to record cardiac morphological and hemody-
namic parameters.
Histological analysis
Mice were euthanatized by using 100% CO2 inhalation for
5 min. For global morphometry, the hearts were perfused with
PBS followed by 4%paraformaldehyde. For histological anal-
ysis, left ventricular tissues were fixed in 10% formalin and
embedded in paraffin, sectioned at 5-μm thickness. The
myocyte cross-sectional area (CSA) was measured with a
quantitative digital image analysis system (Image-Pro Plus
6.0) using images that were captured from FITC-conjugated
wheat germ agglutinin (WGA, Invitrogen Corp)-stained sec-
tions. More than 100 myocytes in the examined sections were
outlined for each group of mice. Evidence of interstitial and
perivascular collagen deposition was visualized by using
picrosirius red (PSR) andMasson’s trichrome staining by light
microscopy, respectively. Myocardial fibrosis area (MFA) and
perivascular fibrosis area (PVF) were calculated by the fol-
lowing formula: MFA = the collagen area/ventricular wall ar-
ea and PVF = perivascular collagen area/the vascular wall
area, respectively. For measurements, five random high-
power fields from each section were chosen and quantified
in a blinded manner. Five sections for each heart were count-
ed. The original images were measured by using an automated
image analysis system (Image-Pro Plus5.0, Media
Cybernetics, USA). All histological quantifications were per-
formed by two observers in a blinded manner.
Real-time quantitative RT-PCR
Total RNA was prepared from the left ventricular tissues of
human hearts, mouse hearts, or cultured cardiac fibroblasts
(cFBs) by using TRIzol reagent (Invitrogen, catalogue
15596–018, USA). cDNA was synthesized from 1-mg RNA
of each sample by using the TOYOBO ReverTra Ace-α-RT-
PCR kit according to the manufacturer’s instruction. Real-
time PCR was performed on a Bio-Rad IQ5 multicolor detec-
tion system by using synthesized cDNA. A comparative CT
method was used to determine relative quantification of spe-
cial RNA levels. All real-time PCRs were performed at least in
triplicates. Collagen type I (Coll. I), collagen type III (Coll.
III), atrial natriuretic peptide (ANP), B-type natriuretic peptide
(BNP), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were amplified by using their specific primers
listed in supplementary table 1.
Co-immunoprecipitation and Western blot
Total protein of cultured cFBs and homogenized left ventric-
ular tissues were extracted by the methods described previous-
ly [15]. Proteins of cellular nucleus were extracted using the
Nuclear Extraction Kit (Millipore Inc., USA) according to the
manufacturer’s instruction. The concentration of protein was
measured by Bicinchoninic Acid Assay kit (Sigma-Aldrich,
USA). A total 500-μg protein was used for co-immunoprecip-
itation. The immuno-complexes were precipitated with pro-
tein A/G Plus-Agarose (Santa Cruz Biotechnology Inc, USA),
anti-total HSF1, and anti-total Smad3. The immuno-
complexes were then subjected to the SDS-PAGE for detect-
ing amounts of binding Smad3 and HSF1. To test the stability
of the Co-IP system, the protein extracts of the WTmouse LV
were used for the input. The samples of negative control were
from protein extracts without the incubation of respective pri-
mary antibodies. The level of phosphorylated HSF1, total
HSF1, phosphorylated Smad3, total Smad3, Coll. I, Coll. III,
and Lamin B1 (LMNB1) were detected by Western blot (all
primary antibodies were purchased from Santa Cruz
Biotechnology Inc, USA). GAPDH detected by Western blot
(Kangcheng Bio-Tech Inc. China) served as the internal con-
trol. The immunoreactivity was detected by Pro-Light chemi-
luminescent detection kit (Tiangen Biotech Inc, China) with
LAS-3000 imaging system (Fujifilm Inc, Japan).
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Glutathione S-transferase (GST) pull-down assay
GST fusion HSF1, Smad3, and GST control proteins
were expressed in Escherichia coli BL21 cells [17].
Briefly, following induction with 0.3 mM of isopropyl-
b-D-thiogalactoside (IPTG) overnight at 16 °C, GST fu-
sion proteins were purified from bacterial crude cell ly-
sates according to the manufacturer’s instructions (Pierce,
USA). Binding assays were performed by pre-incubating
the GST or GST fusion HSF1 (Smad3) proteins beads
with 100 μg/ml bovine serum albumin (BSA) in a bind-
ing buffer (50 mM Tris pH 7.5, 28 μM ZnCl2, 1% Triton
×100, 220 mM NaCl, 10% glycerol) at 4 °C for 1 h. The
beads were centrifuged, re-suspended in binding buffer
and incubated with 10 ng of recombinant Smad3
(HSF1) at 4 °C for 1 h. Beads were then washed three
times with binding buffer containing 500 mM NaCl. The
beads were mixed with 1× SDS-PAGE sample loading
buffer and incubated at 95 °C for 10 min. The protein
mixtures were separated on a 4 to 20% polyacrylamide
gel. The protein bands were blotted onto a nitrocellulose
membrane and probed using a Smad3 or HSF1 antibody.
Statistical analysis
Data are shown as mean ± SEM. Multiple group compar-
ison was performed by one-way or two-way ANOVA
followed by LSD procedure for comparison of means.
Comparison between two groups under identical condi-
tions was performed by the two-tailed Student’s t test. A
value of P < 0.05 was considered statistically significant.
Results
HSF1 activity was decreased in fibrotic hearts and cardiac
fibroblasts after pressure overload
To address whether HSF1 was involved in the myocar-
dial fibrotic response to mechanical stress, we tested
whether pressure overload inactivates HSF1 in vivo.
C57BL/6 mice were subjected to TAC surgery. At
2 weeks after TAC, we observed significant concentric
cardiac hypertrophy manifested with increased LV wall
thickness, LV weight/tibia length (LVW/TL), and cross-
sectional area (CSA), but preserved LV internal diameter
end diastole (LVIDd) and LV ejection fraction (EF)
(Supplementary Table 2). However, no remarkable fibro-
sis was observed in the TAC mouse hearts (Fig. 1a).
Neither mRNA nor protein level of Coll. I and III were
increased at 2 weeks after TAC (Fig. 1b, c). Western blot
showed that the phosphorylation of HSF1 was preserved
at 2 weeks after TAC (Fig. 1d).
Maladaptive cardiac hypertrophy and exacerbated car-
diac dysfunction, evaluated by echocardiography and he-
modynamic measurement, were found in mice at 4 weeks
after TAC (Supplementary Table 2). Expectedly, signifi-
cant cardiac interstitial and perivascular fibrosis was ob-
served in mice at 4 weeks after TAC (Fig. 1a).
Accordingly, the mRNA and protein level of Coll. I
and Coll. III were all notably increased (Fig. 1b, c).
With the development of the cardiac fibrosis, the phos-
phorylation of HSF1 was decreased (Fig. 1d).
Furthermore, in vitro-cultured adult WT mouse cFBs
were subjected to mechanical stretch in the silicon plates
as described previously [18]. The mRNA expressions of
fibrotic markers including Coll. I and Coll. III were sig-
nificantly increased by mechanical stretch time depen-
dently (Fig. 1e). Accordingly, the protein levels of Coll.
I and Coll. III were both increased by mechanical stretch
(Fig. 1f). Inversely, the phosphorylation of HSF1 was
significantly decreased by mechanical stretch in a time-
dependent manner (Fig. 1g).
To explore the potential role of HSF1 in the human
cardiac fibrosis, we analyzed the activation and expres-
sion of HSF1 in the fibrotic hearts from dilated cardio-
myopathy (DCM) patients. Total proteins were extracted
from LV samples of DCM patients undergoing heart
transplantations from end-stage heart failure (HF) and
those of donors. Increased mRNA levels of ANP, BNP,
Coll. I, and Coll. III were found in the failing DCM
hearts by using real-time PCR (Supplementary Fig. 1a).
The protein levels of Coll. I and Coll. III were increased
by 10.1-fold and 18.4-fold in failing hearts compared
with donor hearts, respectively (Supplementary Fig. 1b).
As Phosphorylation of HSF1 (p-HSF1) at Ser230 posi-
tively contributes to the transcriptional activity of HSF1
[19], the level of p-HSF1 at Ser230 was used to evaluate
the activity of HSF1 in failing heart extracts. The level
of p-HSF1 in the whole homogenate was reduced by
Fig. 1 HSF1 phosphorylation was decreased in the fibrotic mouse hearts
and mechanically stretched cFBs. a Histological sections of the left
ventricles of C57BL/6 mice (n = 6) were stained with picrosirius red or
Masson’s trichrome at 2 and 4 weeks after TAC surgery. Left, represen-
tative images; right, quantitative results. Scale bar 50 μm. Fibrotic areas
of the histological sections were quantified using an image analysis sys-
tem. MFA myocardial fibrosis area, PVF perivascular fibrosis area. b
Real-time PCR analysis of Coll. I and Coll. III in C57BL/6 mouse hearts
after sham or TAC surgery (n = 6). c, d Representative Western blots of
Coll. I, Coll. III, total HSF1, and phosphorylated HSF1 in the mouse
hearts after sham or TAC surgery (n = 6). e Real-time PCR analysis of
Coll. I and Coll. III in 10-week-old C57BL/6 mouse heart cFBs after
mechanical stretch for different durations. f, g Representative Western
blots of Coll. I, Coll. III, total HSF1, and phosphorylated HSF1 in cFBs
(n = 6). Values represent mean ± SEM. *P < 0.01 compared with sham
mouse hearts. #P < 0.01 compared with control. †P < 0.01 compared with
stretch for 6 h. P < 0.05 compared with stretch for 12 h. Two-way
ANOVA test was used
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74% in human failing hearts compared to healthy hearts
(Supplementary Fig. 1c). The phosphorylation of Smad3
was notably increased in fibrotic hearts (Supplementary
Fig. 1d).
Taken together, the negative correlation between the HSF1
activation and fibrotic response to pressure overload revealed
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Overexpression of HSF1 inhibits pressure
overload-induced cardiac fibrosis and consequently
rescues cardiac dysfunction
The HSF1 TG mice overexpress a constitutively active form
of HSF1. Although the level of total HSF1 are similar between
the HSF1 TG mice and the WT littermates, Western blot anal-
ysis of the cardiac extracts revealed that the level of phosphor-
ylation of HSF1 at Ser230 was increased by threefold in the
HSF1 TGmice compared with the wild-type (WT) littermates
(Supplementary Fig. 2).
We found that HSF1 activity was decreased in pathological
hearts, fibrotic mouse hearts, and mechanically-stretched
cFBs; therefore, we decided to investigate the functional con-
tribution of HSF1 to cardiac fibrosis in vivo. The HSF1 TG
mice did not show any abnormalities in their cardiac morphol-
ogy and functions at basal condition (Supplementary Table 3).
WT and HSF1 TG mice showed similar increase of blood
pressure at 4 weeks after TAC (Supplementary Table 4).
However, significant cardiac interstitial and perivascular fi-
brosis were observed in the WT mouse hearts, which was
notably reduced by 62 and 58% in the HSF1 TGmice, respec-
tively (Fig. 2a). These results were confirmed by the mRNA
levels of fibrotic markers, Coll. I and Coll. III (Fig. 2b). The
protein levels of Coll. I and Coll. III were both significantly
restrained in the HSF1 TG mice compared with their WT
littermates (Fig. 2c), indicating an attenuated fibrotic response
to pressure overload in the HSF1 TG mouse hearts compared
with the WT mice.
At 4 weeks after TAC, the HSF1 TG mouse cardiac func-
tion was preserved compared with the WTmice evidenced by
the measurement of echocardiography (Fig. 2d). Also, de-
creased LVW/TL ratio, LW/TL ratio, CSA, and downregulat-
ed mRNA expression of hypertrophic markers such as ANP
and BNP were observed in the HSF1 TGmice compared with
the WTmice, implicating an anti-hypertrophic effect of HSF1
against pressure overload (Fig. 2e, f). Taken together, these
findings uncovered that HSF1 overexpression is capable of
suppressing pressure overload-induced cardiac fibrosis and
maladaptive cardiac hypertrophy.
Deficiency of HSF1 exaggerates cardiac fibrosis
and dysfunction induced by pressure overload
Given the evidence indicating that HSF1 overexpression in-
hibits cardiac fibrosis upon pressure overload, we sought to
determine whether a deficiency of HSF1 could augment pres-
sure overload-induced cardiac fibrosis. To this end, the HSF1
KO mice were used in this study. The HSF1 KO mice did not
show any abnormalities in their cardiac morphology and func-
tions (Supplementary Table 5). The level of phosphorylation
of HSF1 in cardiac is reduced by a striking 71% in the HSF1
KO mice compared with the WT littermates despite of a pre-
served protein level of total HSF1 (Supplementary Fig. 2).
Heart rate and body weights were preserved in the WTand
the HSF1 KO mice although the blood pressure was signifi-
cantly increased after TAC for 4 weeks (Supplementary
Table 6). At 4 weeks after TAC, both MFA and PVF in the
hearts of the HSF1 KO mice were increased by 1.7-fold com-
pared with the hearts from the WT littermates, indicating an
aggravated cardiac fibrosis in the hearts of the HSF1 KOmice
(Fig. 3a). Consistent with the above histological test, the ex-
pressions of fibrotic markers Coll. I and Coll. III at both
mRNA and protein levels were significantly increased in the
HSF1 KO mouse hearts (Fig. 3b, c). The HSF1 KO mice also
displayed a pronounced eccentric cardiac hypertrophy mani-
fested by notably increased LVIDd, decreased LVEF, and pre-
served LVAWd compared with the WT mice (Fig. 3d).
Accordingly, increased LVW/TL ratio, LW/TL ratio, and
CSA as well as mRNA expression of ANP and BNP were
observed in the HSF1 KO mice compared with the WT mice,
suggesting an exaggerated maladaptive cardiac remodeling in
the HSF1 - deficient mice treated by chronic pressure overload
(Fig. 3e, f). These data together demonstrate that HSF1 defi-
ciency promotes cardiac fibrosis and exacerbates the cardiac
dysfunction in response to pressure overload.
We next tested the cardioprotective effect of HSF1 in an-
other isoproterenol-induced cardiac fibrosis model. The HSF1
TG, HSF1 KO, and their WT littermates received continuous
administration of isoproterenol or 0.9% saline for 4 weeks
through subcutaneously implanted osmotic minipumps.
Similar to the model of pressure overload-induced cardiac
Fig. 2 HSF1 TGmice were protected fromTAC-induced cardiac fibrosis
and cardiac dysfunction. a Picrosirius red and Masson’s trichrome stain-
ing of histological sections of the HSF1 TG and their WT littermate
mouse left ventricles (LVs) at 4 weeks after TAC (n = 5 mice per exper-
imental group; scale bar 50 μm). Left, representative images; right, quan-
titative results. Fibrotic areas of the histological sections were quantified
using an image analysis system. MFA myocardial fibrosis area, PVF
perivascular fibrosis area. b Real-time PCR analysis of Coll. I and Coll.
III in mouse hearts after sham or TAC surgery (n = 5 per experimental
group). c Representative Western blots of Coll. I, Coll. III, total HSF1,
and phosphorylated HSF1 in indicated mouse LVs (n = 5 per experimen-
tal group). d Parameters of echocardiographic results for the WT and
HSF1 TG mice. LVAWd left ventricular anterior wall end-diastolic thick-
ness, LVIDd left ventricular internal end-diastolic dimensions, LVEF left
ventricular ejection fraction (n = 5 per experimental group). eHistological
analysis of whole hearts (scale bar = 1mm), hematoxylin and eosin (HE)-
stained (scale bar = 20 μm), and wheat germ agglutinin (WGA)-stained
(scale bar = 20 μm) wild-type (WT) and HSF1 TG mouse hearts at
4 weeks after TAC surgery (n = 5 mice per experimental group; scale
bars 20 μm). Left, representative images; right, quantitative results of
the ratios of left ventricular weight/tibal length (LVW/TL), lung weight/
tibal length (LW/TL), and myocardial cross-sectional area (CSA, n =
100+ cells per group). f Real-time PCR analysis of ANP and BNP in-
duced by TAC in the indicated mice (n = 5 per experimental group).
Values represent mean ± SEM. *P < 0.05 compared with WT sham;
#P < 0.05 compared with WT TAC. Two-way ANOVA test was used
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fibrosis, isoproterenol perfusion significantly increased MFA
and PVF, as well as the mRNA expression of collagens I and
III. These fibrotic responses were notably restrained in the
HSF1 TG mice, while exaggerated in the HSF1 KO mice
(Supplementary Tables 7 and 8).
HSF1 inhibits mechanical stretch-induced fibrotic
response in cardiac fibroblast
Considering that chronic overexpression or deletion of HSF1
in vivo may have compensatory effects, which influence the
activity of HSF1 in pressure overload-induced cardiac fibrosis,
we then performed ex vivo studies using cardiac fibroblasts
isolated from WT, HSF1 TG, and HSF1 KO mouse hearts.
We firstly measured the phosphorylation of HSF1 in the
HSF1 TG, KO and their WT littermates. The phosphorylation
level of HSF1 in the cardiac fibroblasts is increased by 4.2-fold
in the HSF1 TG mouse heart, while decreased by 90% in the
HSF1KOmice.Mechanical stretch significantly increased both
mRNA and protein levels of Coll. I and Coll. III. These fibrotic
markers were both notably reduced in cFBs from the HSF1 TG
mice, while boosted in cFBs from the HSF1 KO mice
(Fig. 4b, c). Taken together, these findings indicate that HSF1
inhibits the fibrotic response in cFBs led by mechanical stress.
Considering the vital role of cardiomyocytes (CMs) in car-
diac fibrosis [20], we also tested the effect of HSF1 on the
fibrotic responses of CMs to mechanical stress. To address this
issue, we first performed gain- and loss-of-function studies in
cultured NRCMs. We infected NRCMs with either HSF1 ade-
novirus (AdHSF1) to overexpress HSF1 and increase HSF1
activity or HSF1 shRNA adenovirus (AdshHSF1) to knock-
down HSF1 and decrease its activity. Sustained mechanical
stretch for 24 h raised the level of both mRNA and protein of
CTGF in NRCMs, which was markedly abrogated by infection
of AdHSF1, whereas promoted by infection of AdshHSF1
(Supplementary Fig. 3).
HSF1 inhibits the activation and nuclear translocation
of Smad3
Since Smad3 is a key transcriptional factor in cardiac fibrosis,
we measured the phosphorylation of Smad3 in both the pres-
sure overloaded mouse hearts and the mechanically stretched
cFBs. We observed that 4 weeks after TAC, the phosphoryla-
tion of Smad3 was decreased by 59% in the HSF1 TG mouse
hearts (Fig. 5a), whereas increased by 2.2-fold in the HSF1 KO
mice compared with those hearts of the WT mice (Fig. 5b).
Similarly, the phosphorylation of Smad3 in mechanical-
stretched cFBs was reduced by 63% in HSF1 TG mice, while
increased by 2.1-fold in the HSF1 KOmice, compared with the
control cFBs (Fig. 5c, d).
Smad3 was phosphorylated at the SSXS motif in the C-
terminal tail. Phosphorylated Smad3 translocated from
cytoplasm into nucleus to modulate the development of fibrosis
[21, 22]. The cytoplasmic and nuclear fraction of the mouse
hearts and cultured neonatal rat cFBs were subjected to
Western blot analysis in the present study. The phosphorylated
levels of Smad3 in total protein both cytoplasmic extracts and
nuclear fractions of the HSF1 TG mouse heart extracts were
decreased compared with the WT mice (Fig. 5a). However, the
decrease of Smad3 phosphorylation is more significant in nu-
cleus than cytoplasm evidenced by 50% reduction of nucleus/
cytoplasm concentration ratio of phosphorylated Smad3 in the
HSF1 TG mice compared with the WT mice (Fig. 5a).
Inversely, the nucleus/cytoplasm concentration ratio of phos-
phorylated Smad3 in the HSF1 KO mouse hearts increased
by 3.2-fold compared with the WT mouse hearts, suggesting
that the increased level of Smad3 phosphorylation in the HSF1
KO mouse heart was largely attributed to the increased phos-
phorylated Smad3 in nucleus (Fig. 5b). Similar to in vivo ob-
servations, the decrease of phosphorylated Smad3 in nucleus
was more significant than the decrease in cytoplasm from me-
chanically stretched cFBs from the HSF1 TG mice (Fig. 5c),
whereas HSF1 KO significantly increased the phosphorylated
Smad3 in nucleus of cFBs imposed with mechanical stretch
(Fig. 5c). These results together imply that HSF1 activity reg-
ulates Smad3 activation and nuclear translocation.
HSF1-mediated anti-fibrotic effect is Smad3 dependent
Next, we examined whether activation or inactivation of the
Smad3 signaling cascade would affect the regulatory role of
HSF1 in the development of cardiac fibrosis. To address this
Fig. 3 Deficiency of HSF1 exaggerated pressure overload-induced car-
diac fibrosis. (a) Picrosirius red and Masson’s trichrome staining of his-
tological sections of the HSF1 TG and their WT littermate mouse left
ventricles (LVs) at 4 weeks after TAC (n = 5mice per experimental group;
scale bar 50 μm). Left, representative images; right, quantitative results.
Fibrotic areas of the histological sections were quantified using an image
analysis system.MFAmyocardial fibrosis area, PVF perivascular fibrosis
area. b Real-time PCR analysis of Coll. I and Coll. III in mouse hearts
after sham or TAC surgery (n = 5 per experimental group). c
Representative Western blots of Coll. I, Coll. III, total HSF1, and phos-
phorylated HSF1 in mouse hearts (n = 5 per experimental group). d
Parameters of echocardiographic results of the WT and the HSF1 KO
mice. LVAWd left ventricular anterior wall end-diastolic thickness,
LVIDd left ventricular internal end-diastolic dimensions, LVEF left ven-
tricular ejection fraction (n = 5 per experimental group). e Histological
analysis of whole hearts (scale bar = 2mm), hematoxylin and eosin (HE)-
stained (scale bar = 20 μm), and wheat germ agglutinin (WGA)-stained
(scale bar = 20 μm) wild-type (WT) and HSF1 KO mouse hearts at
4 weeks after TAC surgery (n = 5 mice per experimental group; scale
bars 20 μm). Left, representative images; right, quantitative results of
the ratios of left ventricular weight/tibal length (LVW/TL), lung weight/
tibal length (LW/TL), and myocardial cross-sectional area (CSA, n =
100+ cells per group). f Real-time PCR analysis of hypertrophic markers,
ANP, and BNP induced by TAC in the indicated mice (n = 5 per exper-
imental group). Values represent mean ± SEM. *P < 0.05 compared with
respective sham; #P < 0.05 compared with WT TAC. Two-way ANOVA
test was used
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issue, the cFBs isolated from adult mouse hearts were infected
with Smad3 adenovirus (AdSmad3) before mechanical stretch
for 24 h. BothmRNA and protein levels of collagens I and III in
cFBs from the WT mouse were significantly increased, which
was promoted by infection of AdSmad3. Mechanical stretch
did not increase the expression of these fibrotic markers in the
HSF1 TG mouse heart cFBs infected with AdGFP. However,
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control
stretch
Fig. 4 HSF1 inhibits mechanical stretch-induced fibrotic response in
mouse cardiac fibroblast. a Representative Western blots of total and
phosphorylated HSF1in cardiac fibroblasts from mouse with different
genotypes (n = 4 independent experiments). Up, representative blots.
Below, quantitative results. b Real-time PCR analysis of fibrotic markers
(Coll. I and Coll. III) in cFBs from the HSF1 TG and KO mouse hearts
after the treatment with mechanical stretch for 24 h (n = 4 independent
experiments). cRepresentativeWestern blots and their quantitative results
of Coll. I and Coll. III in cFBs (n = 4 independent experiments). Values
represent mean ± SEM. *P < 0.05 vs. respective control; #P < 0.05 vs.
respective stretch. Two-way ANOVA test was used
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upregulated by mechanical stretch, indicating that inhibition of
Smad3 is the keymechanismmediating theHSF1-induced anti-
fibrotic effect (Fig. 6a, b).
As stress-induced Smad3 activation and nuclear transloca-
tion play critical roles in cardiac fibrosis and remodeling [8],
our finding of HSF1-mediated Smad3 inhibition prompted us
to examine whether HSF1 directly interacted with Smad3. We
firstly performed co-immunoprecipitation (co-IP) experiments
to test the binding of HSF1 and Smad3 in both the HSF1 TG
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Fig. 5 HSF1 inhibits the activation and nuclear translocation of Smad3.
a, b Representative Western blots and quantitative results of the Smad3
phosphorylation and total levels in the HSF1 TG and KO mice 4 weeks
after TAC, respectively (n = 5). c, d Representative Western blots and
quantitative results of the Smad3 phosphorylation and total levels in the
mechanically - stretched cFBs from the HSF1 TG and KO mice, respec-
tively (n = 4 independent experiments). Values represent mean ±
SEM.*P < 0.05 vs. respective sham or control cFBs; #P < 0.05 vs. respec-
tive TAC or stretched cFBs. Two-way ANOVA test was used
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boosted bindings of HSF1 and Smad3 were detected in HSF1
TGmouse hearts, which was preserved after TAC for 4 weeks
(Fig. 6c). However, much less binding was observed in HSF1
KOmouse hearts (Fig. 6c). Then we performed co-IP assay in
cFBs treated by mechanical stretch for 24 h. We found that
HSF1 could co-precipitate along with Smad3 which is signif-
icantly inhibited by mechanical stretch time dependently
(Fig. 6d). GST pull-down assay showed that Smad3 and
HSF1 bind directly (Fig. 6e). As HSP90/HSP70 physiologi-
cally binds with HSF1, we assumed that HSP90 and HSP70
also bind to Smad3. However, our results did not show any
binding between HSP90/HSP70 and Smad3 (Supplementary
Fig. 4). Taken together, these data suggested that Smad3 was
regulated by HSF1 via direct interaction with HSF1.
Discussion
In the present study, we for the first time identified HSF1 as an
important protective regulator of cardiac fibrosis induced by
pressure overload. We firstly unraveled that mechanical stress
decreased the HSF1 activation both in vivo and in vitro in a
time-dependent manner. We also found that HSF1 is
inactivated in failing and fibrotic human hearts. In animal
experiments, HSF1 TGmice showed alleviative cardiac fibro-
sis in response to pressure overload along with relived patho-
logical cardiac hypertrophy and preserved cardiac function. In
contrast, HSF1 KO mice exhibited deteriorated fibrotic re-
sponses and worsened cardiac dysfunction after TAC surgery.
In ex vivo experiments, we demonstrated that HSF1 overex-
pression significantly inhibited mechanical stretch-induced fi-
brosis, whereas HSF1 knockdown increased this fibrotic re-
sponse to mechanical stretch in cardiac fibroblasts.
Overexpression of Smad3 blocked the anti-fibrotic effect of
HSF1 in mechanical-stretched cardiac fibroblasts. We further
illuminated that HSF1 binds directly to Smad3, thus regulat-
ing the activation and translocation of Smad3, which conse-
quently inhibited cardiac fibrosis. Therefore, HSF1 upregula-
tion may provide a new therapeutic strategy for the treatment
of cardiac fibrosis induced by diseases such as hypertension,
aortic valvular stenosis, and aortic constriction.
The mechanisms of cardiac fibrotic response to pressure
overload are extremely complex, including cell membrane
receptors, signal transduction pathways, and inflammation,
as well as transcriptional and posttranscriptional regulation
of genes [3]. Since cardiac fibrosis plays a critical role in the
adverse outcomes of pathological cardiac remodeling, great
efforts were exerted to look for cardioprotective cytokines to
relieve cardiac fibrosis. HSF1, a serine-rich constitutively
phosphorylated mediator of the stress response, is an impor-
tant transcription factor for heat shock proteins and a definite
protective factor in the heart [10, 23–25]. Upon stress, HSF1
forms trimers, relocalizes to nuclear granules, undergoes
inducible phosphorylation, and acquires the properties of a
transactivator. Ser230 is identified as a site of endogenous
phosphorylation on human HSF1 located in the regulatory
domain which promotes the magnitude of the inducible tran-
scriptional activity of HSF1 [26].
So far, it is unknown whether HSF1 is involved in human
cardiac fibrosis. One of our observations in the present study
is that HSF1 activity was significantly reduced in fibrotic
hearts from DCM patients compared with healthy donors.
Cardiac fibrosis accounts, at least in part, for maladaptive
cardiac remodeling in DCM patients [27]. Although pressure
overload is not the cause of cardiac fibrosis of the DCM pa-
tients, we identified a negative relationship between cardiac
fibrosis and the activity of HSF1.
In the present study, HSF1 phosphorylation was gradually
decreased in the pressure overload-induced cardiac fibrosis
time dependently in vivo and in vitro. The phosphorylation
level of HSF1 in fibroblasts was significantly decreased with-
in 12 h by mechanical stretch, while pressure overload could
not change the phosphorylation level of HSF1 in ventricular
tissues at 2 weeks. The following reasons may be responsible
for the different response time to the mechanical stimuli be-
tween in vivo and in vitro studies. First of all, in the in vitro
study, what we detected is the phosphorylation level of HSF1
in mechanical-stretched fibroblasts; however, the phosphory-
lation level of HSF1 detected in ventricular tissues was not
only due to fibroblasts but also due to many other cells.
Secondly, the adaptive neuroendocrine changes after TAC op-
eration may attribute to the longer response of hearts to pres-
sure overload. We thus concluded that pressure overload can
restrain HSF1 activation.
Fig. 6 HSF1-mediated anti-fibrotic effect is Smad3 dependent. a Real-
time PCR analysis of fibrotic markers (Coll. I and Coll. III) in cFBs
transduced with indicated adenovirus and treated with mechanical stretch
for 24 h (n = 4 independent experiments). b RepresentativeWestern blots
and quantitative results of the fibrotic markers (Coll. I and Coll. III) in
cFBs after transduction with indicated adenovirus and treatment with
mechanical stretch for 24 h (n = 5 independent experiments). c Total
proteins extracted from LV of indicated mice were immunoprecipitated
(IP) with antibodies against t-HSF1 (top) or Smad3 (bottom) and then the
immune complexes were subjected to Western blot (WB) analysis for
Smad3 or HSF1, respectively. d Total protein was extracted from cultured
cFBs from the WT mouse heart infected by indicated adenoviruses and
mechanically- stretched for 6, 12, and 24 h, respectively. Total protein
was use to do immunoprecipitation by using antibodies against HSF1
(top) or Smad3 (bottom), and then, the immune complexes were detected
by Smad3 or HSF1 antibodies, respectively. e Glutathione S-transferase
(GST) pull-down assay to detect the direct interaction between HSF1 and
Smad3. Pull-down assay was performed with various concentrations of
GST-HSF1 (0–100 ng) protein (upper panel) or GST-Smad3 (0–100 ng)
protein (lower panel). Concentration-dependent increase in interaction
between Smad3 and HSF1 protein was detected. Glutathione S-
transferase (GST) was used as a loading control. Values represent mean
± SEM. *P < 0.05 vs. respective control; #P < 0.05 vs. respective stretch.
Two-way ANOVA test was used
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Overexpression of HSF1 inhibits pressure overload-induced
cardiac fibrosis and cardiac dysfunction. Conversely, the defi-
ciency of HSF1 exaggerates pressure overload-induced cardiac
fibrosis and dysfunction. Loss of HSF1 in the HSF1 KO mouse
cardiac fibroblasts augmented fibrotic response of cFBs to me-
chanical stretch, indicating that the reduction of HSF1 activation
may promote the progression of cardiac fibrosis. Meanwhile, our
results also uncovered that increased phosphorylation level of
HSF1 significantly abrogated the fibrotic response to mechanical
stretch in cFBs. These findings together indicate that HSF1 acti-
vation is critically involved in the cardiac fibrotic response to
pressure overload. Xie et al. showed that isoproterenol induced
significant and similar cardiac fibrosis in the Kunming mice and
the HSF1−/+ mice, which was very slight in the HSF1−/− mice
[28], indicating a detrimental effect of HSF1 on cardiac fibrosis
induced by isoproterenol. However, we drew a different conclu-
sion based on an amelioration of cardiac fibrosis in HSF1 TG
mice treated with isoproterenol. In the past 10 years, other
group’s studies together with ours have identified HSF1 as an
endogenous cardioprotective factor [12–14, 23, 24, 29]. Actually,
we had reported the protective effect of HSF1 against cardiac
fibrosis induced by pressure overload in 2011 [14]; however,
the mechanism is still unclear. Since our results are inconsistent
with theirs, the following reasons should be considered. Different
methods were used to evaluate the cardiac fibrosis. They used
hematoxylin and eosin staining to observe fibrosis in the hearts.
However, we used picrosirius red and Masson’s trichrome stain-
ing, which are two kinds of canonical methods evaluating organ
fibrosis [30]. Furthermore, real-time PCR and WB detecting the
collagens I and III were used to evaluate the cardiac fibrosis in
the present study. The different observation methods may con-
tribute to the different conclusions.
HSF1 plays a protective role in cardiac fibrosis induced by
pressure overload. However, the underlying mechanism by
which HSF1 prevents cardiac fibrosis and inhibits heart failure
remains unclear. Accumulating evidences have indicated that
numerous transcription factors including signal transducer and
activator of transcription 3 (STAT3), protein kinase C (PKC),
Smad3, Smad family member 4 (Smad4), and P38 are in-
volved in the initiation and development of cardiac fibrosis
[21, 31–34]. Therefore, it is worthy to examine whether the
expressions/activities of these transcription factors are inter-
fered by HSF1 in hearts upon chronic pressure overload. We
detected the expression of STAT3, PKC, Smad3, Smad4, and
P38 in the TAC-induced fibrotic hearts collected from both the
HSF1TG and KO mice by immunoblotting (data not shown).
Smad3 was the only one to be regulated in fibrotic hearts by
HSF1. Thus, HSF1-mediated regulation of cardiac fibrosis
may be directly associated with Smad3. As an essential down-
stream transcription factor of tissue growth factor β (TGFβ),
Smad3 mediates TGFβ signaling to regulate cardiac fibrotic
response to pressure overload and ischemic stimulations [6, 8,
35, 36]. Pressure overload, partly mediated by the angiotensin
II receptor 1, activates the TGFβ receptor 1 and phosphory-
lates downstream Smad3 [8, 37]. After phosphorylation,
Smad3 translocates from the cytoplasm to the nucleus and
promotes the transcription of multiple pro-fibrotic factors in-
cluding CTGF, periostin, and TGFβ [8, 21, 38]. Inhibition of
Smad3 phosphorylation ameliorated the pressure overload-
induced cardiac fibrosis and cardiac dysfunction in mouse
[21]. Notably, under basal condition, either overexpression
or inhibition of HSF1 in mouse hearts did not alter both the
total and phosphorylated Smad3; however, on pressure over-
load, phosphorylated Smad3 was increased in the HSF1 KO
mice, but decreased in the HSF1 TGmice. These data suggest
that HSF1-mediated regulation of Smad3 might be stress de-
pendent. Indeed, this is supported by our data showing that
blockage of Smad3 activation offsets the HSF1-elicited fibrot-
ic response. Currently, it is well documented that increased
Smad3 expression results in the activation of pro-fibrotic gene
programs (i.e., CTGF, SMA, and collagen), leading to cardiac
fibrosis [5]. In addition, previous studies also suggested that
the activation of Smad3 was essential for pressure overload or
AngII-induced myocardial fibrosis [8, 20, 21, 39]. Together,
the data from co-IP, GST pull-down and immunostaining as-
says together indicated an interaction between p-HSF1 and
unphoshoryated Smad3. Although our results might not ex-
clude other mechanisms by which HSF1 suppresses cardiac
fibrosis induced by pressure overload, the inhibitory effect of
HSF1 on the development of cardiac fibrosis seems to be
largely dependent on the suppression of Smad3 by HSF1.
In conclusion, our present work provides the first evidence
that cardiac HSF1 activation inhibits cardiac fibrosis in re-
sponse to pressure overload via inhibition of the Smad3 phos-
phorylation and translocation (Fig. 7). We propose that
targeting of the HSF1 may develop novel promising strategies













Fig. 7 A diagram describing HSF1 mediated amelioration of cardiac
fibrosis
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with disease such as hypertension, aortic valvular stenosis,
and aortic constriction.
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